Addition of Chemoradiation to Neoadjuvant mFOLFIRINOX Shows No Benefit in BRPC
Results from the phase 2 PANDAS/PRODIGE 44 trial did not show any benefit from the addition of chemoradiation to neoadjuvant mFOLFIRINOX in patients with BRPC.
Read MoreSep 30, 2024
Results from the phase 2 PANDAS/PRODIGE 44 trial did not show any benefit from the addition of chemoradiation to neoadjuvant mFOLFIRINOX in patients with BRPC.
Read MoreSep 30, 2024
T-DXd exhibited substantial and durable clinical activity in a large cohort of patients with metastatic HER2+ breast cancer, irrespective of brain metastases,
Read MoreSep 30, 2024
AI use is expanding in dermatology, but experts caution that more research is needed to optimize AI’s functionality for patients with skin of color.
Read MoreSep 30, 2024
In the phase 1/2 ALKOVE-1 trial, the ALK-selective tyrosine kinase inhibitor (TKI) NVL-655...
Read MoreSep 30, 2024
The fields of allergy and immunology may soon see notable increases in mobile health allergy apps and AI use for monitoring treatment adherence and symptoms.
Read MoreSep 30, 2024
Second primary lung cancers (SPLC) may be more common than previously known, with up to 1 in 6 survivors developing SPLC, but research is limited.
Read MoreSep 30, 2024
Using NGS in prognostic assessments enhances myelofibrosis prognosis and survival estimates, representing a step toward personalized medicine in myelofibrosis.
Read MoreSep 30, 2024
A recent study found cell-free DNA liquid profiling accurate and useful in characterizing different types of endometrial cancer and guiding therapy selection.
Read MoreSep 30, 2024
In a recent study in JAMA Network Open, a video storytelling intervention showed promise for helping Hispanic patients with type 2 diabetes reduce their A1C.
Read MoreSep 30, 2024
Emerging data on living donor liver transplant for alcohol-associated hepatitis shows the procedure offers a survival benefit over medical management alone.
Read MoreSep 30, 2024
Improved widespread and systematic counseling on ACS guidelines is needed to increase uptake of healthy behaviors among male and younger cancer survivors.
Read MoreSep 30, 2024
Researchers found the Hospital Anxiety and Depression Scale (HADS) to be a useful tool for anxiety assessment in routine COPD management.
Read MoreSep 30, 2024
An app-based behavioral change program for obesity led to sustained weight loss by changing participants’ perceptions of hunger and satiety.
Read MoreSep 30, 2024
MASH’s economic burden is substantial, particularly for patients with MASH and multiple comorbidities, even in the absence of cirrhosis.
Read MoreSep 30, 2024
A recent literature review highlighted “complex intersections” between intimate partner violence and PrEP care engagement among sexual minority men.
Read MoreSep 30, 2024
A recent review showed that tumor budding was consistently associated with a higher risk for nodal metastases in patients with cutaneous squamous cell carcinoma.
Read MoreSep 30, 2024
Researchers created a Modified Staging System for Waldenström macroglobulinemia that could improve risk stratification for treatment-naïve patients.
Read MoreSep 30, 2024
4D flow MRI may be a viable, non-invasive alternative to right heart catheterization for measuring blood flow in patients with pulmonary arterial hypertension.
Read MoreSep 30, 2024
Researchers developed a clinical practice psoriasis care algorithm designed to foster empathy, trust, and communication between clinicians and patients.
Read MoreSep 30, 2024
A new report from a major CMV research and advocacy group describes changes to how specific CMV-related terms are defined in transplant recipients.
Read More